Haemonetics Corp (NYSE:HAE)

CAPS Rating: 5 out of 5

Designs, manufactures and markets automated systems for the collection, processing and surgical salvage of donor and patient blood, including the single-use disposables used with its systems and related information services and data management software.

Recs

1
Player Avatar goldnmypoc (54.25) Submitted: 3/27/2008 10:33:31 PM : Outperform Start Price: $29.75 HAE Score: -36.31

Steady growth with sales, assets outweigh debt, 10 profitable years, debt definately needs to come down but with the right management this company will continue to do good.

Featured Broker Partners


Advertisement